StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 866.00
+11.00 (1.29%)
At close: Mar 6, 2026
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 8.87 billion as of March 6, 2026. Its market cap has decreased by -41.72% in one year.
Market Cap
8.87B
Enterprise Value
6.69B
Revenue
2.78B
Ranking
n/a
PE Ratio
45.73
Stock Price
866.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 8.87B, a decrease of -58.06%. That is a compound annual growth rate of -16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.87B | 9.21% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellSeed | 11.46B |
| K Pharma,Inc. | 10.11B |
| BrightPath Biotherapeutics | 8.30B |
| MEDINET | 8.00B |
| ADR120S | 7.76B |
| CellSource | 7.57B |
| OncoTherapy Science | 7.53B |
| PRISM BioLab Co.,LTD | 7.46B |